Noticias de ARDX_US
Noticias del mercado
Últimas noticias sobre ARDX_US — 546 novedades recientes. Análisis, balances, opiniones y cobertura de prensa.
Kaplan Fox Continues to Remind Ardelyx, Inc. (NASDAQ: ARDX) Investors of the Lead Plaintiff Deadline on November 16, 2026
Ardelyx filed a $520K third-quarter 2026 lobbying report covering ESRD drug access, pricing, and reimbursement as CMS weighs 2027 ESRD rule. Read more.
/PRNewswire/ -- SueWallSt notifies investors in Ardelyx, Inc. (NASDAQ: ARDX) that a class action has been filed on behalf of shareholders who purchased...
El director financiero dijo en una conferencia que la rentabilidad está “a la vuelta de la esquina”, aunque la empresa está esperando más certezas de primera línea antes de una orientación formal.
Over the last 7 days, the United States market has experienced a 1.6% drop, yet it remains up by 12% over the past year with earnings anticipated to grow by 17% annually in the coming years. In this context, identifying high growth tech stocks that can potentially enhance a portfolio involves looking for companies with strong innovation and adaptability in an evolving market landscape.
/PRNewswire/ -- Shareholder rights law firm Robbins LLP reminds investors that a class action was filed on behalf of persons and entities who purchased or...
CIUDAD DE NUEVA YORK, NY / ACCESS Newswire / 14 de octubre de 2026 / Bronstein, Gewirtz & Grossman, LLC, una firma de abogados de derechos de inversionistas reconocida a nivel nacional, anuncia que se ha presentado una demanda colectiva contra Ardelyx, Inc. (NASDAQ:ARDX) y algunos de sus funcionarios.
NEW YORK, NY - October 14, 2026 (NEWMEDIAWIRE) - Kaplan Fox & Kilsheimer LLP announces that a class action lawsuit has been filed against Ardelyx, Inc. (“Ardelyx” or the “Company”) (NASDAQ: ARDX) on behalf of investors that purchased or otherwise acquired Ardelyx common stock between January 13, 2025 and August 6, 2026 (the “Class Period”).
Página 3 de 28